ABLD Stock Chart & Stats
€2.80
€0.00(0.00%)
At close: 4:00 PM EST
€2.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€2.12 - €5.75
Previous CloseN/A
Volume1.00
Average Volume (3M)1.22K
Market Cap
€40.93M
Enterprise Value€35.86M
Total Cash (Recent Filing)€7.00M
Total Debt (Recent Filing)€180.00
Price to Earnings (P/E)―
Beta0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,114,656
10 Day Avg. Volume2,029
30 Day Avg. Volume1,221
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABLD FAQ
What was ABL Diagnostics SA’s price range in the past 12 months?
ABL Diagnostics SA lowest stock price was €2.12 and its highest was €5.75 in the past 12 months.
What is ABL Diagnostics SA’s market cap?
ABL Diagnostics SA’s market cap is €40.93M.
When is ABL Diagnostics SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ABL Diagnostics SA’s earnings last quarter?
Currently, no data Available
Is ABL Diagnostics SA overvalued?
According to Wall Street analysts ABL Diagnostics SA’s price is currently Overvalued.
Does ABL Diagnostics SA pay dividends?
ABL Diagnostics SA pays a N/A dividend of €0.11 which represents an annual dividend yield of N/A. See more information on ABL Diagnostics SA dividends here
What is ABL Diagnostics SA’s EPS estimate?
ABL Diagnostics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABL Diagnostics SA have?
ABL Diagnostics SA has 16,114,656 shares outstanding.
What happened to ABL Diagnostics SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ABL Diagnostics SA?
Currently, no hedge funds are holding shares in FR:ABLD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ABL Diagnostics SA
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.